drugset / Trial / NCT00190645

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

NCT00190645

Phase 3 Completed 600 enrolled Eli Lilly and Company Boehringer Ingelheim · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The patients are being followed in this study to determine the safety of taking the medication Duloxetine for a long period of time. The patients participating in this study suffer from Stress Urinary Incontinence.

Timeline

Start
2001-02
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule